As of 2025-10-30, the EV/EBITDA ratio of Clal Biotechnology Industries Ltd (CBI.TA) is -2.13. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CBI.TA's latest enterprise value is 68.89 mil ILS. CBI.TA's TTM EBITDA according to its financial statements is -32.29 mil ILS. Dividing these 2 quantities gives us the above CBI.TA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.2x - 19.3x | 15.0x |
| Forward P/E multiples | 20.0x - 26.0x | 26.0x |
| Fair Price | (409.13) - (394.81) | (418.28) |
| Upside | -1382.5% - -1337.6% | -1411.2% |
| Date | EV/EBITDA |
| 2025-10-28 | -2.12 |
| 2025-10-27 | -2.11 |
| 2025-10-26 | -2.11 |
| 2025-10-23 | -2.13 |
| 2025-10-22 | -2.13 |
| 2025-10-21 | -2.10 |
| 2025-10-20 | -2.13 |
| 2025-10-19 | -2.22 |
| 2025-10-16 | -2.33 |
| 2025-10-15 | -2.34 |
| 2025-10-12 | -2.29 |
| 2025-10-09 | -2.39 |
| 2025-10-08 | -2.48 |
| 2025-10-05 | -2.51 |
| 2025-09-30 | -2.45 |
| 2025-09-29 | -2.34 |
| 2025-09-28 | -2.37 |
| 2025-09-25 | -2.25 |
| 2025-09-21 | -2.41 |
| 2025-09-18 | -2.43 |
| 2025-09-17 | -2.44 |
| 2025-09-16 | -2.45 |
| 2025-09-15 | -2.54 |
| 2025-09-14 | -2.67 |
| 2025-09-11 | -2.60 |
| 2025-09-10 | -2.42 |
| 2025-09-09 | -2.35 |
| 2025-09-08 | -2.38 |
| 2025-09-07 | -2.34 |
| 2025-09-04 | -2.19 |
| 2025-09-03 | -2.14 |
| 2025-09-02 | -2.11 |
| 2025-09-01 | -2.09 |
| 2025-08-31 | -1.99 |
| 2025-08-28 | -2.00 |
| 2025-08-27 | -2.04 |
| 2025-08-26 | -2.06 |
| 2025-08-25 | -2.02 |
| 2025-08-24 | -2.06 |
| 2025-08-21 | -2.06 |
| 2025-08-19 | -2.07 |
| 2025-08-18 | -2.07 |
| 2025-08-17 | -2.09 |
| 2025-08-14 | -2.12 |
| 2025-08-13 | -2.12 |
| 2025-08-12 | -2.08 |
| 2025-08-06 | -2.05 |
| 2025-08-05 | -2.18 |
| 2025-08-04 | -2.19 |